Summit Global Investments Bioventus Inc. Transaction History
Summit Global Investments
- $1.6 Billion
- Q4 2024
A detailed history of Summit Global Investments transactions in Bioventus Inc. stock. As of the latest transaction made, Summit Global Investments holds 52,675 shares of BVS stock, worth $539,918. This represents 0.03% of its overall portfolio holdings.
Number of Shares
52,675Holding current value
$539,918% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BVS
# of Institutions
158Shares Held
45.3MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$133 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$71.1 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$41.3 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$25.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$24.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $632M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...